{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:06:58Z","timestamp":1778854018303,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University of Poitiers"},{"name":"R\u00e9gion Poitou-Charente"},{"name":"Alzheimer Society of Canada (N\u00b0 14 19)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.expneurol.2015.06.021","type":"journal-article","created":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T21:10:18Z","timestamp":1435180218000},"page":"308-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Inhibition of GSK3\u03b2 by pharmacological modulation of sphingolipid metabolism occurs independently of ganglioside disturbance in a cellular model of Alzheimer's disease"],"prefix":"10.1016","volume":"271","author":[{"given":"Anastasia","family":"Noel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Ingrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Barrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2015.06.021_bb0005","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2337\/db06-1619","article-title":"Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity","volume":"56","author":"Aerts","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.expneurol.2015.06.021_bb0010","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1194\/jlr.R800007-JLR200","article-title":"Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease\u2014a review","volume":"49","author":"Ariga","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0015","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.neurobiolaging.2006.08.002","article-title":"Genotype-related changes of ganglioside composition in brain regions of transgenic mouse models of Alzheimer's disease","volume":"28","author":"Barrier","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2015.06.021_bb0020","doi-asserted-by":"crossref","first-page":"920958","DOI":"10.4061\/2011\/920958","article-title":"Ceramide and related-sphingolipid levels are not altered in disease-associated brain regions of APP and APP\/PS1 mouse models of Alzheimer's disease: relationship with the lack of neurodegeneration?","volume":"2011","author":"Barrier","year":"2010","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0025","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.neurobiolaging.2008.10.011","article-title":"Gender-dependent accumulation of ceramides in the cerebral cortex of the APP(SL)\/PS1Ki mouse model of Alzheimer's disease","volume":"31","author":"Barrier","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2015.06.021_bb0030","doi-asserted-by":"crossref","first-page":"11074","DOI":"10.1073\/pnas.190297597","article-title":"Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration","volume":"97","author":"Bhat","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0035","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1046\/j.1471-4159.1999.0721040.x","article-title":"Differential effects of glycolipid biosynthesis inhibitors on ceramide-induced cell death in neuroblastoma cells","volume":"72","author":"Bieberich","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bcp.2005.10.004","article-title":"Inhibition of sphingolipid synthesis impairs cellular activation, cytokine production and proliferation in human lymphocytes","volume":"71","author":"Blank","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0045","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2337\/db09-0897","article-title":"Plasma membrane subdomain compartmentalization contributes to distinct mechanisms of ceramide action on insulin signaling","volume":"59","author":"Blouin","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.expneurol.2015.06.021_bb0050","doi-asserted-by":"crossref","first-page":"20313","DOI":"10.1074\/jbc.274.29.20313","article-title":"Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid","volume":"274","author":"Chalfant","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0304-4165(00)00068-4","article-title":"Effects of lithium and insulin on glycogen synthesis in L6 myocytes: additive effects on inactivation of glycogen synthase kinase-3","volume":"1475","author":"Choi","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2015.06.021_bb0060","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.nbd.2008.12.014","article-title":"JNK regulates APP cleavage and degradation in a model of Alzheimer's disease","volume":"33","author":"Colombo","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0065","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neulet.2010.07.016","article-title":"Glycogen synthesis in brain and astrocytes is inhibited by chronic lithium treatment","volume":"482","author":"de Almeida Souza","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2005-7106","article-title":"Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease","volume":"7","author":"de la Monte","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0075","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diabetes.52.3.596","article-title":"Disruption of the striated muscle glycogen targeting subunit PPP1R3A of protein phosphatase 1 leads to increased weight gain, fat deposition, and development of insulin resistance","volume":"52","author":"Delibegovic","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.expneurol.2015.06.021_bb0080","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","article-title":"GSK-3: tricks of the trade for a multi-tasking kinase","volume":"116","author":"Doble","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.abb.2006.10.009","article-title":"Lithium ions increase hepatic glycogen synthase stability through a proteasome-related mechanism","volume":"457","author":"Fernandez-Novell","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0090","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0166-2236(03)00163-2","article-title":"Potential role of insulin and IGF-1 in Alzheimer's disease","volume":"26","author":"Gasparini","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0095","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1210\/en.2006-0750","article-title":"Ceramide-activated protein phosphatase involvement in insulin resistance via Akt, serine\/arginine-rich protein 40, and ribonucleic acid splicing in L6 skeletal muscle cells","volume":"148","author":"Ghosh","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.expneurol.2015.06.021_bb0100","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0301-0082(01)00011-9","article-title":"The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling","volume":"65","author":"Grimes","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0304-3835(03)00459-2","article-title":"N-butyldeoxynojirimycin inhibits murine melanoma cell ganglioside metabolism and delays tumor onset","volume":"201","author":"Guerrera","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0110","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4239\/wjd.v5.i3.244","article-title":"Defect of insulin signal in peripheral tissues: important role of ceramide","volume":"5","author":"Hage Hassan","year":"2014","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.expneurol.2015.06.021_bb0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11010-010-0544-0","article-title":"Regulation of GSK3 isoforms by phosphatases PP1 and PP2A","volume":"344","author":"Hernandez","year":"2010","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0120","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1210\/er.2007-0025","article-title":"Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism","volume":"29","author":"Holland","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0125","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1096\/fj.10-180190","article-title":"Glucosylceramide synthase inhibitor PDMP sensitizes chronic myeloid leukemia T315I mutant to Bcr-Abl inhibitor and cooperatively induces glycogen synthase kinase-3-regulated apoptosis","volume":"25","author":"Huang","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0074-7742(09)85022-8","article-title":"Neurotrophic and neuroprotective actions of an enhancer of ganglioside biosynthesis","volume":"85","author":"Inokuchi","year":"2009","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0130","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/oxfordjournals.jbchem.a124774","article-title":"Stimulation of glycosphingolipid biosynthesis by L-threo-1-phenyl-2-decanoylamino-1-propanol and its homologs in B16 melanoma cells","volume":"117","author":"Inokuchi","year":"1995","journal-title":"J. Biochem."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0135","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1006\/bbrc.1997.7194","article-title":"Up-regulation of ganglioside biosynthesis, functional synapse formation, and memory retention by a synthetic ceramide analog (L-PDMP)","volume":"237","author":"Inokuchi","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0145","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0197-0186(92)90057-X","article-title":"Gangliosides in the human brain development and aging","volume":"20","author":"Kracun","year":"1992","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0150","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.plipres.2009.03.002","article-title":"Glycosphingolipids and insulin resistance","volume":"48","author":"Langeveld","year":"2009","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2990.2006.00795.x","article-title":"Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurons at different stages of neurofibrillary degeneration","volume":"33","author":"Leroy","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0165","first-page":"46","article-title":"GSK-3beta, a pivotal kinase in Alzheimer disease","volume":"7","author":"Llorens-Martin","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0160","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.molcel.2006.10.009","article-title":"A chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylation","volume":"24","author":"Lochhead","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.expneurol.2015.06.021_bb0170","doi-asserted-by":"crossref","first-page":"9509","DOI":"10.1074\/jbc.M411648200","article-title":"Constitutive activation of GSK3 down-regulates glycogen synthase abundance and glycogen deposition in rat skeletal muscle cells","volume":"280","author":"MacAulay","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0175","doi-asserted-by":"crossref","first-page":"479249","DOI":"10.4061\/2011\/479249","article-title":"Deconstructing GSK-3: the fine regulation of its activity","volume":"2011","author":"Medina","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1471-4159.2004.02849.x","article-title":"Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains","volume":"92","author":"Molander-Melin","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0185","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/jnr.22587","article-title":"Lithium chloride and staurosporine potentiate the accumulation of phosphorylated glycogen synthase kinase 3beta\/Tyr216, resulting in glycogen synthase kinase 3beta activation in SH-SY5Y human neuroblastoma cell lines","volume":"89","author":"Noel","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0190","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2007.01.029","article-title":"LTP inhibits LTD in the hippocampus via regulation of GSK3beta","volume":"53","author":"Peineau","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2015.06.021_bb0195","doi-asserted-by":"crossref","first-page":"27108","DOI":"10.1016\/S0021-9258(18)47132-3","article-title":"N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing","volume":"269","author":"Platt","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0200","first-page":"183","article-title":"Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances","volume":"26","author":"Radin","year":"1993","journal-title":"Adv. Lipid Res."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0205","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1476-5381.2008.00085.x","article-title":"Glycogen synthase kinase 3: more than a namesake","volume":"156","author":"Rayasam","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0210","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1128\/MCB.21.8.2683-2694.2001","article-title":"Insulin control of glycogen metabolism in knockout mice lacking the muscle-specific protein phosphatase PP1G\/RGL","volume":"21","author":"Suzuki","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0215","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0079-6123(08)61965-2","article-title":"Ganglioside loss is a primary event in Alzheimer disease type I","volume":"101","author":"Svennerholm","year":"1994","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0220","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1074\/jbc.M103705200","article-title":"Ganglioside GM3 participates in the pathological conditions of insulin resistance","volume":"277","author":"Tagami","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0225","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbrc.2014.12.087","article-title":"Synthetic ceramide analogues increase amyloid-\u03b242 production by modulating \u03b3-secretase activity","volume":"457","author":"Takasugi","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004723","article-title":"Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation","volume":"4","author":"van Eijk","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2015.06.021_bb0235","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/jid.2013.532","article-title":"Ganglioside GM3 depletion reverses impaired wound healing in diabetic mice by activating IGF-1 and insulin receptors","volume":"134","author":"Wang","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0240","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejphar.2004.02.048","article-title":"Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease","volume":"490","author":"Watson","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0245","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1073\/pnas.0635898100","article-title":"Enhanced insulin sensitivity in mice lacking ganglioside GM3","volume":"100","author":"Yamashita","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0250","series-title":"Neurobiology of Glycoconjugates","first-page":"1","article-title":"Structure and localization of gangliosides","author":"Yu","year":"1989"},{"key":"10.1016\/j.expneurol.2015.06.021_bb0255","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11010-011-1086-9","article-title":"1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) facilitates curcumin-induced melanoma cell apoptosis by enhancing ceramide accumulation, JNK activation, and inhibiting PI3K\/AKT activation","volume":"361","author":"Yu","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.expneurol.2015.06.021_bb0260","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2337\/db06-0719","article-title":"Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes","volume":"56","author":"Zhao","year":"2007","journal-title":"Diabetes"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488615300315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488615300315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T21:11:34Z","timestamp":1748466694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488615300315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":52,"alternative-id":["S0014488615300315"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2015.06.021","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of GSK3\u03b2 by pharmacological modulation of sphingolipid metabolism occurs independently of ganglioside disturbance in a cellular model of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2015.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}